216 related articles for article (PubMed ID: 18668553)
21. Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.
Bankhurst AD; Williams RC
J Clin Invest; 1975 Dec; 56(6):1378-85. PubMed ID: 1081549
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus.
Katsiari CG; Liossis SN; Souliotis VL; Dimopoulos AM; Manoussakis MN; Sfikakis PP
Clin Immunol; 2002 Apr; 103(1):54-62. PubMed ID: 11987985
[TBL] [Abstract][Full Text] [Related]
23. Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus.
Gladman D; Keystone E; Urowitz M; Cane D; Poplonski L
Clin Exp Immunol; 1980 Apr; 40(1):77-82. PubMed ID: 6156046
[TBL] [Abstract][Full Text] [Related]
24. The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus.
Huang W; Sinha J; Newman J; Reddy B; Budhai L; Furie R; Vaishnaw A; Davidson A
Arthritis Rheum; 2002 Jun; 46(6):1554-62. PubMed ID: 12115186
[TBL] [Abstract][Full Text] [Related]
25. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH
J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
[TBL] [Abstract][Full Text] [Related]
26. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production.
Takeno M; Nagafuchi H; Kaneko S; Wakisaka S; Oneda K; Takeba Y; Yamashita N; Suzuki N; Kaneoka H; Sakane T
J Immunol; 1997 Apr; 158(7):3529-38. PubMed ID: 9120315
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of T suppressor activity in systemic lupus erythematosus].
Balestrieri G; Tincani A; Fenini G; Cattaneo R
Boll Ist Sieroter Milan; 1982; 61(4):330-5. PubMed ID: 6242136
[TBL] [Abstract][Full Text] [Related]
28. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
[TBL] [Abstract][Full Text] [Related]
29. Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE.
Liu TF; Jones BM
Cytokine; 1998 Feb; 10(2):148-53. PubMed ID: 9512905
[TBL] [Abstract][Full Text] [Related]
30. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.
Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I
J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522
[TBL] [Abstract][Full Text] [Related]
31. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.
Liossis SN; Kovacs B; Dennis G; Kammer GM; Tsokos GC
J Clin Invest; 1996 Dec; 98(11):2549-57. PubMed ID: 8958217
[TBL] [Abstract][Full Text] [Related]
32. RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies.
Kikuchi Y; Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Horiuchi T; Nagasawa K
Arthritis Rheum; 2002 Dec; 46(12):3259-65. PubMed ID: 12483730
[TBL] [Abstract][Full Text] [Related]
33. D-penicillamine: a modulator of anti-DNA antibodies production.
Mach PS; Brouilhet H; Amor B
Clin Exp Immunol; 1986 Feb; 63(2):414-8. PubMed ID: 3486066
[TBL] [Abstract][Full Text] [Related]
34. Concomitant reduction of disease activity and IL-10 secreting peripheral blood mononuclear cells during immunoadsorption in patients with active systenic lupus erythematosus.
Willeke P; Schotte H; Erren M; Schlüther B; Mickholz E; Domschke W; Gaubitz M
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):323-9. PubMed ID: 12030438
[TBL] [Abstract][Full Text] [Related]
35. The in vitro production of anti-DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE patients.
Cairns E; St Germain J; Bell DA
J Immunol; 1985 Dec; 135(6):3839-44. PubMed ID: 3905965
[TBL] [Abstract][Full Text] [Related]
36. Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8
Kato H; Perl A
Front Immunol; 2021; 12():635531. PubMed ID: 33763079
[TBL] [Abstract][Full Text] [Related]
37. Familial alterations of immunoregulation in systemic lupus erythematosus.
Spencer-Green G; Adams LE; Hurtubise P; Kravatz G; Hess EV
J Rheumatol; 1985 Jun; 12(3):498-503. PubMed ID: 2931520
[TBL] [Abstract][Full Text] [Related]
38. Presence of an IL-3-producing suppressor T cell resistant to cyclosporin A in the peripheral blood of patients with systemic lupus erythematosus.
Alcocer-Varela ; Vidaller A; Llorente L; Alarcón-Segovia D
Clin Exp Immunol; 1988 Sep; 73(3):424-9. PubMed ID: 2974765
[TBL] [Abstract][Full Text] [Related]
39. Production of a suppressor factor by human adherent cells treated with Mycobacterium tuberculosis: absence in systemic lupus erythematosus.
Wadee AA; Gear AJ; Rabson AR
Clin Exp Immunol; 1981 Oct; 46(1):82-8. PubMed ID: 6461455
[TBL] [Abstract][Full Text] [Related]
40. B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus.
Becker H; Schauer U; Helmke K
Clin Exp Immunol; 1986 Nov; 66(2):365-72. PubMed ID: 3102135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
